Director Kevin P. Clark filed a Form 4 with the SEC on September 22, 2026, reporting the acquisition of dividend equivalent rights tied to restricted stock units in Versigent PLC, with the earliest transaction dated September 18, 2026.

Key Highlights

  • Reporting person: Kevin P. Clark, listed as a Director of Versigent PLC (NYSE:VGNT).
  • Transaction type: Acquisition (Code A) of 14.65 Dividend Equivalent Rights on September 18, 2026.
  • Price: The derivative securities were acquired at a price of $0.00.
  • Post-transaction holdings: Clark beneficially owned 14.65 Dividend Equivalent Rights following the reported transaction, held directly.
  • Nature of rights: According to the filing, the rights "accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer" and vest on the same schedule as the underlying restricted stock units.
  • Economic equivalence: The filing states that "each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares."
  • Filing signed by: Janis N. Acosta, Attorney-in-fact for Kevin P. Clark, on September 22, 2026.

Dividend Equivalent Rights Accrued on Clark's Restricted Stock Units at Versigent PLC

According to the Form 4 filed with the SEC, Kevin P. Clark, a Director of Versigent PLC (NYSE:VGNT), acquired 14.65 Dividend Equivalent Rights on September 18, 2026. The filing classifies these as derivative securities under Table II, acquired at a price of $0.00, and identifies the underlying security as ordinary shares of the issuer.

The filing's explanation of responses states that these rights "accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer." The rights are not immediately exercisable on their own terms; rather, they vest according to the same schedule as the restricted stock units to which they relate. The filing further notes that each right "is the economic equivalent of one share of the issuer's ordinary shares." Following this transaction, Clark directly beneficially owned 14.65 Dividend Equivalent Rights, as reported in the filing.

Clark's address is listed in the filing as Spitalstrasse 5, Schaffhausen, Switzerland. The form was filed by one reporting person and was not designated as an amendment to a prior filing. The filing was signed by Janis N. Acosta as Attorney-in-fact for Kevin P. Clark on September 22, 2026.

What Was Disclosed

The filing reported Director Kevin P. Clark's acquisition of 14.65 Dividend Equivalent Rights in Versigent PLC at no cost, accrued on existing restricted stock unit grants following a dividend declared and paid by the issuer, with vesting tied to the underlying restricted stock units.